TABLE 2.
Association between the patients’ clinical characteristics and FANCD2 expression levels in GBM patients.
| Characteristics | Low Expression of FANCD2 | High Expression of FANCD2 | p Values |
|---|---|---|---|
| N | 348 | 348 | — |
| WHO grade | — | — | <0.001 |
| G2 | 180 (28.3%) | 44 (6.9%) | — |
| G3 | 113 (17.8%) | 130 (20.5%) | — |
| G4 | 19 (3%) | 149 (23.5%) | — |
| IDH status | — | — | <0.001 |
| WT | 54 (7.9%) | 192 (28%) | — |
| Mut | 291 (42.4%) | 149 (21.7%) | — |
| 1p/19q codeletion | — | — | <0.001 |
| codel | 119 (17.3%) | 52 (7.5%) | — |
| non-codel | 228 (33.1%) | 290 (42.1%) | — |
| Age | — | — | — |
| — | 40 (32, 52) | 52 (37.75, 62.25) | <0.001 |